What You Should Know:
- DNAnexus, Inc., a global provider of a leading enterprise platform for precision health data, has announced its intention to bring precision medicine capabilities to select Oracle Health clinical applications.
- The goal of this collaboration is to incorporate genomic data into the clinical setting, which can help power new medical advances and support better, more personalized treatment plans.
Integrating Genomics Data Infrastucture with Oracle EHR
The
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Proscia Launches AI Solution to Advance Precision Medicine
What You Should Know:
- Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of diagnosis.
- The AI-powered tool aims to tackle one of healthcare’s most significant challenges: connecting patients with life-saving therapies and accelerating the development of new treatments.
Transforming Pathology Data Into Real-Time
Read More
Beyond One-Size-Fits-All: A Guide to Precision Medicine and Personalized Healthcare
Personalized medicine, also known as precision medicine, is redefining healthcare by tailoring medical treatment to the unique characteristics of each individual. This approach integrates genetic, environmental, and lifestyle factors to enhance disease prevention, diagnosis, and treatment. The potential benefits of precision medicine are profound, and include numerous foundations and applications which we will explore in this piece. It must be noted, however, that the implementation of
Read More
Unlocking the Power of Genomics in Clinical Trials: A Precision Medicine Data Imperative
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics and biomarker-based insights. These trials not only test therapeutic efficacy but also help identify which patients are most likely to benefit, reducing trial-and-error in treatment and transforming hope into more predictable outcomes. With nearly half a million clinical trials underway globally, the potential to
Read More
InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities
What You Should Know:
- InformedDNA®, a precision health company focused on revolutionizing the application of genomic insights, has announced its acquisition of Coriell Life Sciences, a provider of pharmacogenomic services and clinical decision support. Financial details of the acquisition were not disclosed.
- The strategic acquisition significantly expands InformedDNA's capabilities, offering patients, providers, and payers broader access to genetic insights for more
Read More
Tempus Acquires Precision Research Platform Deep 6 AI
What You Should Know:
- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies.
- Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate recruitment, and generate real-world evidence (RWE) with speed and precision. Its AI-powered software matches
Read More
M42 and Rhapsody Partner to Advance Precision Medicine and Global Health Interoperability
What You Should Know:
- Global health leader M42, which is powered by artificial intelligence (AI) and technology, has announced a groundbreaking partnership with Rhapsody, a leading digital health enablement platform, to empower precision medicine initiatives across the UAE and beyond.
-This collaboration, powered by Microsoft Azure, aims to redefine healthcare data integration and enhance global health outcomes by delivering cutting-edge solutions for seamless and scalable
Read More
Quibim Secures $50M to Advance AI-Powered Imaging Biomarkers for Precision Medicine
What You Should Know:
- Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing.
- The company has experienced remarkable growth in the number of patients analyzed by its products over the past year. Driven by several regulatory approvals and global commercial partnerships, patient analysis surged by 168% quarter-on-quarter.
Quibim: Advancing Precision Medicine Through
Read More
Precision Medicine 2.0: How AI-Driven Insights Are Changing Healthcare for the Better
A patient arrives at a clinic with constant chest pain. In a conventional approach, a doctor would likely conduct a range of standard tests, prescribe medication, and suggest lifestyle modifications, striving for an optimal result. Now, envision a scenario where an AI system seamlessly analyzes the patient’s genetic profile, medical records, and wearable device data in real time to identify the most effective treatment tailored specifically to them.
This is not the future—it is the reality
Read More
UCSF and GE HealthCare Launch Care Innovation Hub to Advance Medical Imaging and Precision Medicine
What You Should Know:
- The University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE HealthCare have joined forces to establish a Care Innovation Hub, a collaborative research initiative focused on addressing critical clinical challenges in medical imaging and treatment.
- The Care Innovation Hub leverages the strengths of both academia and industry to translate novel technologies into clinical practice, ultimately improving patient care
Read More
